Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23)

The purpose of this Notice of Amendment is to notify about the additions of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary use: Brexucabtagene autoleucel; Idecabtagene vicleucel; Pitolisant; Risdiplam; Selpercatinib; Solriamfetol; Tepotinib; Tildrakizumab; Trastuzumab; deruxtecan.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification avril 17, 2026, 21:30 (TU)
Créé le avril 17, 2026, 21:30 (TU)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-07-19 00:00:00
open_canada_keywords {"fr": ["avis de modification", "Liste des drogues sur ordonnance", "LPD", "ingrédients médicinaux", "usage humain et vétérinaire", "Brexucabtagene autoleucel", "Idecabtagene vicleucel", "Pitolisant", "Risdiplam", "Selpercatinib", "Solriamfetol", "Tepotinib", "Tildrakizumab", "Trastuzumab", "deruxtecan"], "en": ["notice of amendment", "Prescription Drug List", "PDL", "medicinal ingredients", "human-and-veterinary use", "Brexucabtagene autoleucel", "Idecabtagene vicleucel", "Pitolisant", "Risdiplam", "Selpercatinib", "Solriamfetol", "Tepotinib", "Tildrakizumab", "Trastuzumab", "deruxtecan"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Avis : Liste des drogues sur ordonnance (LDO) : additions multiples (2021-07-23)
update_frequency as_needed